Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$153K Sell
26,876
-79,112
-75% -$342K ﹤0.01% 3374
2026
Q1
$410K Buy
105,988
+56,320
+113% +$231K 0.01% 2217
2025
Q4
$208K Buy
49,668
+10,005
+25% +$38.7K 0.01% 2373
2025
Q3
$130K Sell
39,663
-94,197
-70% -$266K 0.01% 1959
2025
Q2
$190K Buy
+133,860
New +$190K 0.01% 1725
2025
Q1
Sell
-77,609
Closed -$86.9K 2931
2024
Q4
$86.9K Buy
+77,609
New +$66.2K 0.01% 1797
2024
Q1
Sell
-66,162
Closed -$88.7K 2198
2023
Q4
$88.7K Sell
66,162
-61,413
-48% -$72.2K 0.02% 1140
2023
Q3
$181K Sell
127,575
-135,471
-52% -$192K 0.03% 1048
2023
Q2
$303K Sell
263,046
-151,671
-37% -$179K 0.05% 715
2023
Q1
$440K Buy
414,717
+108,385
+35% +$156K 0.09% 377
2022
Q4
$466K Buy
306,332
+269,367
+729% +$463K 0.1% 331
2022
Q3
$78K Sell
36,965
-35,933
-49% -$75.8K 0.02% 982
2022
Q2
$98K Buy
72,898
+17,703
+32% +$26.3K 0.04% 649
2022
Q1
$116K Buy
55,195
+41,443
+301% +$101K 0.05% 493
2021
Q4
$51K Buy
+13,752
New +$59.2K 0.03% 560
2021
Q2
Sell
-14,070
Closed -$97K 1029
2021
Q1
$97K Buy
+14,070
New +$119K 0.05% 569

Other funds holding PGEN

XTX Topco's PGEN Position: Q2 2026 in Review

XTX Topco reduced its Precigen (PGEN) stake by 75% in Q2 2026, selling an estimated $342K and leaving 26,876 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #3374.

XTX Topco first reported a position in PGEN in Q1 2021 and has held it in 16 quarters since. The position peaked at $466K in Q4 2022. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • XTX Topco held 26,876 shares of Precigen worth $153K as of Q2 2026.
  • XTX Topco sold 79,112 Precigen shares in Q2 2026, an estimated $342K.
  • Precigen made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3374 holding.
  • XTX Topco first reported a position in Precigen in Q1 2021 and has held it in 16 quarters since.
  • XTX Topco's Precigen position peaked at $466K in Q4 2022.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.